Search Results - "Świtaj, Tomasz"

Long‐term efficacy of neoadjuvant–adjuvant targeted therapy in borderline resectable stage IIIB–D and IV melanoma by Czarnecka, Anna M., Ostaszewski, Krzysztof, Błoński, Piotr J., Szumera‐Ciećkiewicz, Anna, Świtaj, Tomasz, Kozak, Katarzyna, Koseła‐Patreczyk, Hanna, Rogala, Paweł, Kalinowska, Iwona, Zaborowski, Konrad, Krotewicz, Maria, Borkowska, Aneta, Rutkowski, Piotr

“…Background Neoadjuvant–adjuvant therapy for locally advanced or potentially resectable metastatic melanoma was expected to improve operability and clinical…”
Get full text

The clinical prognostic factors and treatment outcomes of adult patients with Ewing sarcoma by Jagodzińska-Mucha, Paulina, Ługowska, Iwona, Świtaj, Tomasz, Koseła-Paterczyk, Hanna, Wągrodzki, Michał, Kozak, Katarzyna, Falkowski, Sławomir, Morysiński, Tadeusz, Goryń, Tomasz, Dawidowska, Anna, Rutkowski, Piotr

“…Background The data about treatment results of Ewing sarcoma in adult patients are limited. The aim of our study was to analyze prognostic factors and outcomes…”
Get full text

What is the best front-line approach in patients with desmoid fibromatosis? – A retrospective analysis from a reference center by Sobczuk, Paweł, Agnieszczak, Izabela M., Grycuk, Wiktoria, Czarnecka, Anna M., Świtaj, Tomasz, Koseła-Paterczyk, Hanna, Morysiński, Tadeusz, Zdzienicki, Marcin, Rutkowski, Piotr

“…Desmoid fibromatosis (DF) is a locally aggressive, not metastasizing tumor associated with high local recurrence rates. Surgery was a standard-of-care for DF…”
Get full text

Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence by Czarnecka, Anna Małgorzata, Sobczuk, Paweł, Rogala, Paweł, Świtaj, Tomasz, Placzke, Joanna, Kozak, Katarzyna, Mariuk-Jarema, Anna, Spałek, Mateusz, Dudzisz-Śledź, Monika, Teterycz, Paweł, Borkowska, Aneta, Rutkowski, Piotr

“…Immunotherapy (ITH) holds the possibility of tumor burden decrease after initial RECIST 1.1 defined progression. The clinical concept of treating selected…”
Get full text

Genetics of rare mesenchymal tumors: Implications for targeted treatment in DFSP, ASPS, CCS, GCTB and PEComa by Rutkowski, Piotr, Przybył, Joanna, Świtaj, Tomasz

“…Soft tissue and bone sarcomas comprise a heterogeneous group of mesenchymal tumors that include roughly 130 distinct diagnostic entities. Many of them are…”
Get full text

Preoperative-postoperative immunotherapy as treatment of borderline resectable and oligoprogressive stage III B-D and IV melanoma by Czarnecka, Anna M., Ostaszewski, Krzysztof, Błoński, Piotr, Szumera-Ciećkiewicz, Anna, Kozak, Katarzyna, Placzke, Joanna, Borkowska, Aneta, Terlecka, Anna, Rogala, Paweł, Świtaj, Tomasz, Sałamacha, Maciej, Mitręga-Korab, Beata, Krotewicz, Maria, Dudzisz-Śledź, Monika, Rutkowski, Piotr

“…Perioperative therapy has gained significant importance in patients with advanced melanoma. Currently, there is little data on the routine use of preoperative…”
Get full text

Management Strategies for Adults with Locally Advanced, Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa): Challenges and Solutions by Czarnecka, Anna M, Skoczylas, Jacek, Bartnik, Ewa, Świtaj, Tomasz, Rutkowski, Piotr

“…PEComa (PEC tumor; perivascular epithelioid cell tumors) is a rare group of tumors of mesenchymal origin composed of perivascular epithelioid cells (PEC) with…”
Get full text

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study by Rutkowski, Piotr, Bylina, Elżbieta, Klimczak, Anna, Switaj, Tomasz, Falkowski, Sławomir, Kroc, Jacek, Lugowska, Iwona, Brzeskwiniewicz, Magdalena, Melerowicz, Wojciech, Osuch, Czesław, Mierzejewska, Ewa, Wasielewski, Kacper, Woźniak, Agnieszka, Grzesiakowska, Urszula, Nowecki, Zbigniew I, Siedlecki, Janusz A, Limon, Janusz

“…Gastrointestinal stromal tumors (GIST) mutational status is recognized factor related to the results of tyrosine kinase inhibitors therapy such as imatinib…”
Get full text

Efficacy of Sirolimus Treatment in PEComa-10 Years of Practice Perspective by Świtaj, Tomasz, Sobiborowicz, Aleksandra, Teterycz, Paweł, Klimczak, Anna, Makuła, Donata, Wągrodzki, Michał, Szumera-Ciećkiewicz, Anna, Rutkowski, Piotr, Czarnecka, Anna M

“…Perivascular epithelioid cell tumors (PEComa) represent a family of rare mesenchymal tumors resultant from deregulation in mTOR pathway activity. The aim of…”
Get full text

Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk Wall by Koseła-Paterczyk, Hanna, Teterycz, Paweł, Spałek, Mateusz, Borkowska, Aneta, Zawadzka, Anna, Wągrodzki, Michał, Szumera-Ciećkiewicz, Anna, Morysiński, Tadeusz, Świtaj, Tomasz, Ługowska, Iwona, Castaneda-Wysocka, Patrycja, Zdzienicki, Marcin, Goryń, Tomasz, Rutkowski, Piotr

“…Background: The use of adjuvant radiotherapy (RT) shows a significantly decreased incidence of local recurrence (LR) in soft tissue sarcomas (STS). This study…”
Get full text

Long-term outcomes of sequential chemotherapy in epithelioid sarcoma by Czarnecka, Anna M, Chmiel, Paulina, Błoński, Piotr, Świtaj, Tomasz, Rogala, Paweł, Falkowski, Sławomir, Koseła-Paterczyk, Hanna, Teterycz, Paweł, Kopeć, Sylwia, Morysiński, Tadeusz, Wągrodzki, Michał, Rutkowski, Piotr

“…Our study was carried out to define the efficacy of treatment with sequential chemotherapy lines in patients with epithelioid sarcoma (ES) at referral centres…”
Get full text

Feasibility and Long-Term Efficacy of PEComa Treatment—20 Years of Experience by Sobiborowicz, Aleksandra, Świtaj, Tomasz, Teterycz, Paweł, Spałek, Mateusz J., Szumera-Ciećkiewicz, Anna, Wągrodzki, Michał, Zdzienicki, Marcin, Czarnecka, Anna M., Rutkowski, Piotr

“…Perivascular epithelioid cell tumors (PEComas) represent a family of rare mesenchymal neoplasms, some of which are malignant. There are no specific management…”
Get full text

Real-world outcomes of metastatic clear cell sarcoma sequential chemotherapy by Czarnecka, Anna M, Chmiel, Paulina, Błoński, Piotr J, Świtaj, Tomasz, Rogala, Paweł, Falkowski, Sławomir, Koseła-Paterczyk, Hanna, Teterycz, Paweł, Morysiński, Tadeusz, Spałek, Mateusz, Wągrodzki, Michał, Rutkowski, Piotr

“…Clear cell sarcoma is an ultra-rare chemoresistant subtype of soft tissue sarcoma. This retrospective analysis aimed to clarify the efficacy of palliative…”
Get full text

Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment by Chmiel, Paulina, SłOWIKOWSKA, Aleksandra, Banaszek, Łukasz, Szumera-CIEćKIEWICZ, Anna, Szostakowski, BARTłOMIEJ, SPAłEK, Mateusz J, Świtaj, Tomasz, Rutkowski, Piotr, Czarnecka, Anna M

“…Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm with intermediate malignancy characterized by a propensity for recurrence but a low metastatic…”
Get full text

The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice by Rutkowski, Piotr, Ziętek, Marcin, Cybulska-Stopa, Bożena, Streb, Joanna, Głuszek, Stanisław, Jankowski, Michał, Łopacka-Szatan, Karolina, Las-Jankowska, Manuela, Hudziec, Piotr, Klimczak, Anna, Olesiński, Tomasz, Świtaj, Tomasz, Koseła-Paterczyk, Hanna, Bylina, Elżbieta, Osuch, Czesław

“…The real-world data on adjuvant imatinib therapy in high-risk primary GIST are scarce. We have analysed the data of 107 consecutive patients with…”
Get full text

The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma by Sobczuk, Paweł, Kozak, Katarzyna, Kopeć, Sylwia, Rogala, Paweł, Świtaj, Tomasz, Koseła-Paterczyk, Hanna, Gos, Aleksandra, Tysarowski, Andrzej, Rutkowski, Piotr

“…Assessment of mutation status is mandatory in advanced, treatment-naïve melanoma patients. Liquid biopsy can be an alternative in cases with inadequate or…”
Get full text

Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors by Janik, Anna Maria, Terlecka, Anna, Spałek, Mateusz J, Boye, Kjetil, Szostakowski, Bartłomiej, Chmiel, Paulina, Szumera-Ciećkiewicz, Anna, Bobak, Klaudia, Świtaj, Tomasz, Rutkowski, Piotr, Czarnecka, Anna M

“…Solitary fibrous tumors (SFT) are rare mesenchymal neoplasms that account for less than 2% of all soft tissue masses. In the latest WHO 2020 Classification of…”
Get full text

Long-term Results of Therapy with Sunitinib in Metastatic Alveolar Soft Part Sarcoma by Jagodzińska-Mucha, Paulina, Świtaj, Tomasz, Kozak, Katarzyna, Koseła-Paterczyk, Hanna, Klimczak, Anna, Ługowska, Iwona, Rogala, Pawel, Wągrodzki, Michał, Falkowski, Sławomir, Rutkowski, Piotr

“…Background Alveolar soft part sarcoma (ASPS) is a rare, highly vascularized soft tissue sarcoma characterized by a high frequency of metastatic disease and…”
Get full text

Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells by JALILI, Ahmad, MAKOWSKI, Marcin, SIENKO, Jacek, SIERON, Aleksander, ADAMEK, Mariusz, BASAK, Grzegorz, MROZ, Pawet, KRASNODEBSKI, Ireneusz W, JAKOBISIAK, Marek, GOLAB, Jakub, SWITAJ, Tomasz, NOWIS, Dominika, WILCZYNSKI, Grzegorz M, WILCZEK, Ewa, CHORAZY-MASSALSKA, Magdalena, RADZIKOWSKA, Anna, MASLINSKI, Wlodzimierz, BIALY, Lukasz

“…Purpose: The unique mechanism of tumor destruction by photodynamic therapy (PDT), resulting from apoptotic and necrotic killing of tumor cells accompanied by…”
Get full text

Malignant peripheral nerve sheath tumors – Outcomes and prognostic factors based on the reference center experience by Sobczuk, Paweł, Teterycz, Paweł, Czarnecka, Anna M., Świtaj, Tomasz, Koseła-Paterczyk, Hanna, Kozak, Katarzyna, Falkowski, Sławomir, Goryń, Tomasz, Zdzienicki, Marcin, Morysiński, Tadeusz, Rutkowski, Piotr

“…Malignant peripheral nerve sheath tumor (MPNST) accounts for about 5% of soft tissue sarcomas. It can occur as sporadic diseases or can be associated with type…”
Get full text